Thermal balloon endometrial ablation in the treatment of heavy XXXX .

@entity1 @entity3556 @entity548 @entity931 @entity2588
AIM: Heavy @entity548 is one of the common health problems in @entity1 . The first-line therapy of heavy @entity548 is the medical therapy, but this is not successful. Currently, global ablation procedures were introduced for treating of heavy @entity548 . The aim of this study was to the analysis of the @entity1 with @entity931 performed operations of Cavaterm in our university affiliated hospital, and explores its effectiveness and acceptability. METHODS: A retrospective study was conducted on 30 @entity1 with @entity931 who were unresponsive to hormone therapy or not candidates for hysterectomy underwent endometrial ablation using Cavaterm. Preoperative and postoperative PBAC Scoring System was used to assess @entity931 . Outcome measures were @entity2588 rates, reduction of menstrual flow rates, heavy @entity548 , menstrual and @entity1 ' satisfaction rates at 3, 6 and 12 months postoperative. RESULTS: After a follow-up at 3, 6, and 12 months postoperative, 36.7%, 43.3%, and 36.7% of @entity1 had a @entity3556 , respectively. @entity2588 rates were 56.7%, 50.0%, and 56.7% in the Cavaterm at 3, 6, and 12 months. The rate of @entity1 's reported good or excellent satisfaction was 93.3% in 12 months. During the follow-up period, no @entity1 received a subsequent hysterectomy. CONCLUSION: The findings of this research indicated that outcome with the Cavaterm was as good for @entity1 with @entity931 . Therefore, it is necessary to emphasize on lower operative and post-operative procedural risk and a deleterious effect on @entity1 who were unresponsive to hormone therapy.
